FDA advisors reject MDMA therapy for PTSD, amid concerns over research
A panel of advisors to the FDA voted against the potential use of MDMA for treating PTSD.
Source: ketr.org
Stay updated with breaking news from David Millis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A panel of advisors to the FDA voted against the potential use of MDMA for treating PTSD.
A panel of advisors to the FDA voted against the potential use of MDMA for treating PTSD.
The panel's recommendation, based on several concerns about two clinical trials, is a serious setback for a promising PTSD treatment.
A panel of advisors to the FDA voted against the potential use of MDMA for treating PTSD.
A panel of advisors to the FDA voted against the potential use of MDMA for treating PTSD.